Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
Int J Cardiol. 2011 Jul 15;150(2):123-9. doi: 10.1016/j.ijcard.2010.10.018. Epub 2010 Nov 20.
Prevalence of dementing illnesses is expected to grow due to aging of the population throughout the world. Vascular dementia and Alzheimer's disease share several risk factors and are nowadays considered two ends of a continuum rather than two distinct entities. Traditional cardiovascular risk markers such as diabetes, dyslipidemia, hypertension, metabolic syndrome and adiposity in mid-life are harbingers of cognitive decline, Alzheimer's disease and vascular dementia later in life. In aged populations, only diabetes has been more constantly associated with the development of cognitive dysfunction, while other risk markers have shown more mixed results. Normal aging, co-morbidities and other changes connected to cognitive decline make the interpretation of the risk markers in the elderly challenging and probably explain these contradictory findings. Control of cardiovascular risk factors has been linked to beneficial effects in terms of cognition in cross-sectional and prospective follow up studies, but the results of interventional trials have been disappointing. More research in this area is needed, specifically, placebo-controlled randomized trials in both mid-life and late-life with cognitive dysfunction as a primary endpoint.
由于世界各地人口老龄化,痴呆症的发病率预计将会增加。血管性痴呆和阿尔茨海默病有一些共同的危险因素,现在被认为是一个连续体的两个极端,而不是两个截然不同的实体。传统的心血管危险因素标志物,如中年时期的糖尿病、血脂异常、高血压、代谢综合征和肥胖,是认知能力下降、阿尔茨海默病和血管性痴呆的先兆。在老年人群中,只有糖尿病与认知功能障碍的发展更密切相关,而其他危险因素的结果则更为混杂。正常衰老、合并症和其他与认知能力下降相关的变化使得对老年人的风险标志物的解释具有挑战性,这可能解释了这些相互矛盾的发现。控制心血管危险因素与横断面和前瞻性随访研究中认知功能的有益效果有关,但干预试验的结果令人失望。这方面需要更多的研究,特别是在中年和晚年进行以认知功能为主要终点的安慰剂对照随机试验。